Effects of Specific Lipid Fractions-enriched Infant Formulae
Effects of Specific Lipid Fractions-enriched Infant Formulae
This is a multicenter, randomized, double-blind, parallel-group, reference-controlled 4-month
 pilot safety study to evaluate the effects of specific lipid fractions-enriched infant
 formulae on growth of infants aged 0-4 months. The study will test the hypothesis that growth
 of infants fed the specific lipid fractions-enriched infant formulae will be noninferior to
 growth of infants fed standard infant formula.
Inclusion Criteria:

 -  Healthy newborn infant

 -  Infant is ≤14 days old on day of enrollment

 -  Gestational age ≥37 weeks (full term infants)

 -  Birth weight ≥2500 g and ≤4500 g

 -  Singleton birth

 -  Having obtained his/her parents'/legal representative's informed consent

 Exclusion Criteria:

 -  Having any significant pre-natal and/or post-natal disease and/or congenital illness
 or malformation that may affect normal growth.

 -  Infant undergoing antibiotic therapy.

 -  Re-hospitalization for more than 2 days in the first 14 days of life.

 -  Parents not expected to comply with the protocol during the period of study
 participation.

 -  Infants currently participating in another trial